Moderation of nicotine effects on covert orienting of attention tasks by poor placebo performance and cue validity.

What Was Tested

This randomized controlled trial looks at Therapeutic nicotine (patch, non-peptide).

Given baseline-dependent effects of nicotine on other forms of attention, there is reason to believe that inconsistent findings for the effects of nicotine on attentional orienting may be partly due to individual differences in baseline (abstinence state) functioning.

Who Took Part

The age groups tagged for this paper are teenagers, young adults, adults and middle-aged adults, both men and women.

How the Study Was Run

The researchers set it up as a randomized, double-blind and placebo-controlled study.

Random assignment meant chance, not the researchers, decided who got Therapeutic nicotine (patch, non-peptide) and who got the comparison, which limits bias.

Neither the participants nor the staff measuring them knew who was on Therapeutic nicotine (patch, non-peptide), so expectations could not easily colour the readings.

Some participants received a placebo instead of Therapeutic nicotine (patch, non-peptide), giving a reference point.

The effects of nicotine as a function of baseline performance (bottom, middle, and top third of mean reaction times during placebo) were assessed in 52 habitual abstinent smokers (26 females/26 males) utilizing an arrow-cued covert orienting of attention task.

What Was Measured

The subject headings attached to it are Attention, Cues, Nicotine, Orientation, Orientation, Spatial, Reaction Time and Space Perception.

The authors tagged it with the keywords Attentional orienting, Baseline dependency, Covert attention, Smoking and Spatial attention.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Therapeutic nicotine (patch, non-peptide).

Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2016 (Pharmacology, biochemistry, and behavior), a journal based in United States.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.